# Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Advanced Lung Non-Small Cell Carcinoma

- Company: National Cancer Institute (NCI)
- Sector: Advanced Lung Non-Small Cell Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT03191149

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.